Drug reference
Primary immunisation (first dose) ▶BY DEEP INTRAMUSCULAR INJECTION ▶Child 2 months: 0.5 mL for 1 dose Primary immunisation (second dose) ▶BY DEEP INTRAMUSCULAR INJECTION ▶Child 3 months: 0.5 mL for 1 dose, preferably administer at a different injection site to that of first dose Primary immunisation (third dose) ▶BY DEEP INTRAMUSCULAR INJECTION ▶Child 4 months: 0.5 mL for 1 dose, preferably administer at a different injection site to that of second dose
PDF page 1403
Available as part of childhood schedule from health organisations or ImmForm.
PDF page 1403
▶Common or very common Anxiety. crying abnormal ▶Uncommon Cough. drowsiness. extensive swelling of vaccinated limb. increased risk of infection ▶Rare or very rare Angioedema. apnoea. hypotonic- hyporesponsiveness episode. seizure. swelling. thrombocytopenia
PDF page 1403
There can be variation in the licensing of different medicines containing the same drug. Powder and suspension for suspension for injection EXCIPIENTS: May contain Neomycin, polymyxin b ▶Infanrix Hexa (GlaxoSmithKline UK Ltd) Infanrix Hexa vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes | 1 pre-filled disposable injection P s eiiii F 1379
PDF page 1403
0.5 mL for 1 dose
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1403
0.5 mL for 1 dose, preferably administer
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1403
0.5 mL for 1 dose, preferably administer
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1403
